These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23519521)

  • 21. Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome.
    Fang CJ; Fremeaux-Bacchi V; Liszewski MK; Pianetti G; Noris M; Goodship TH; Atkinson JP
    Blood; 2008 Jan; 111(2):624-32. PubMed ID: 17914026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical hemolytic uremic syndrome.
    Loirat C; Frémeaux-Bacchi V
    Orphanet J Rare Dis; 2011 Sep; 6():60. PubMed ID: 21902819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.
    Sellier-Leclerc AL; Fremeaux-Bacchi V; Dragon-Durey MA; Macher MA; Niaudet P; Guest G; Boudailliez B; Bouissou F; Deschenes G; Gie S; Tsimaratos M; Fischbach M; Morin D; Nivet H; Alberti C; Loirat C;
    J Am Soc Nephrol; 2007 Aug; 18(8):2392-400. PubMed ID: 17599974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome.
    Caprioli J; Noris M; Brioschi S; Pianetti G; Castelletti F; Bettinaglio P; Mele C; Bresin E; Cassis L; Gamba S; Porrati F; Bucchioni S; Monteferrante G; Fang CJ; Liszewski MK; Kavanagh D; Atkinson JP; Remuzzi G;
    Blood; 2006 Aug; 108(4):1267-79. PubMed ID: 16621965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies.
    Phillips EH; Westwood JP; Brocklebank V; Wong EK; Tellez JO; Marchbank KJ; McGuckin S; Gale DP; Connolly J; Goodship TH; Kavanagh D; Scully MA
    J Thromb Haemost; 2016 Jan; 14(1):175-85. PubMed ID: 26559391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome.
    Moore I; Strain L; Pappworth I; Kavanagh D; Barlow PN; Herbert AP; Schmidt CQ; Staniforth SJ; Holmes LV; Ward R; Morgan L; Goodship TH; Marchbank KJ
    Blood; 2010 Jan; 115(2):379-87. PubMed ID: 19861685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome.
    Fremeaux-Bacchi V; Moulton EA; Kavanagh D; Dragon-Durey MA; Blouin J; Caudy A; Arzouk N; Cleper R; Francois M; Guest G; Pourrat J; Seligman R; Fridman WH; Loirat C; Atkinson JP
    J Am Soc Nephrol; 2006 Jul; 17(7):2017-25. PubMed ID: 16762990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A missense mutation in factor I (IF) predisposes to atypical haemolytic uraemic syndrome.
    Geelen J; van den Dries K; Roos A; van de Kar N; de Kat Angelino C; Klasen I; Monnens L; van den Heuvel L
    Pediatr Nephrol; 2007 Mar; 22(3):371-5. PubMed ID: 17106690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD46-associated atypical hemolytic uremic syndrome with uncommon course caused by cblC deficiency.
    Bouts AH; Roofthooft MT; Salomons GS; Davin JC
    Pediatr Nephrol; 2010 Dec; 25(12):2547-8. PubMed ID: 20652818
    [No Abstract]   [Full Text] [Related]  

  • 30. Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree.
    Esparza-Gordillo J; Jorge EG; Garrido CA; Carreras L; López-Trascasa M; Sánchez-Corral P; de Córdoba SR
    Mol Immunol; 2006 Apr; 43(11):1769-75. PubMed ID: 16386793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemolytic uremic syndrome with Mycoplasma pneumoniae infection and membrane cofactor protein mutation – case report.
    Miklaszewska M; Zachwieja K; Drożdż D; Pállinger É; Takács B; Szilágyi Á; Csuka D; Prohászka Z
    Przegl Lek; 2016; 73(11):862-4. PubMed ID: 29693967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical hemolytic uremic syndrome: update on the complement system and what is new.
    Hirt-Minkowski P; Dickenmann M; Schifferli JA
    Nephron Clin Pract; 2010; 114(4):c219-35. PubMed ID: 20090363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation.
    Le Quintrec M; Lionet A; Kamar N; Karras A; Barbier S; Buchler M; Fakhouri F; Provost F; Fridman WH; Thervet E; Legendre C; Zuber J; Frémeaux-Bacchi V
    Am J Transplant; 2008 Aug; 8(8):1694-701. PubMed ID: 18557729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of atypical hemolytic uremic syndrome in a second renal transplant.
    Zwang NA; Ho B; Kanwar YS; Lewis B; Cusick M; Friedewald JJ; Gallon L
    J Nephrol; 2018 Feb; 31(1):165-172. PubMed ID: 28224376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of genetic and predisposing factors in Japanese patients with atypical hemolytic uremic syndrome.
    Fan X; Yoshida Y; Honda S; Matsumoto M; Sawada Y; Hattori M; Hisanaga S; Hiwa R; Nakamura F; Tomomori M; Miyagawa S; Fujimaru R; Yamada H; Sawai T; Ikeda Y; Iwata N; Uemura O; Matsukuma E; Aizawa Y; Harada H; Wada H; Ishikawa E; Ashida A; Nangaku M; Miyata T; Fujimura Y
    Mol Immunol; 2013 Jun; 54(2):238-46. PubMed ID: 23314101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome.
    Weitz M; Amon O; Bassler D; Koenigsrainer A; Nadalin S
    Pediatr Nephrol; 2011 Aug; 26(8):1325-9. PubMed ID: 21556717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations in CD46, a complement regulatory protein, predispose to atypical HUS.
    Goodship TH; Liszewski MK; Kemp EJ; Richards A; Atkinson JP
    Trends Mol Med; 2004 May; 10(5):226-31. PubMed ID: 15121049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome.
    Schaefer F; Ardissino G; Ariceta G; Fakhouri F; Scully M; Isbel N; Lommelé Å; Kupelian V; Gasteyger C; Greenbaum LA; Johnson S; Ogawa M; Licht C; Vande Walle J; Frémeaux-Bacchi V;
    Kidney Int; 2018 Aug; 94(2):408-418. PubMed ID: 29907460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transplantation in atypical hemolytic uremic syndrome.
    Kavanagh D; Richards A; Goodship T; Jalanko H
    Semin Thromb Hemost; 2010 Sep; 36(6):653-9. PubMed ID: 20865642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Common genetic variants in complement genes other than CFH, CD46 and the CFHRs are not associated with aHUS.
    Ermini L; Goodship TH; Strain L; Weale ME; Sacks SH; Cordell HJ; Fremeaux-Bacchi V; Sheerin NS
    Mol Immunol; 2012 Jan; 49(4):640-8. PubMed ID: 22153652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.